United States · FDA National Drug Code directory

PAROXETINE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 68180-647_1a9bc25c-db83-42a0-851a-30212ee10cc6
Product NDC: 68180-647
Form: TABLET, FILM COATED, EXTENDED RELEASE
Composition / generic term: PAROXETINE
Labeler: Lupin Pharmaceuticals, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20170306
Source listing expiry: 20261231

Source-listed ingredients

PAROXETINE HYDROCHLORIDE HEMIHYDRATE — 12.5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

Package details are not available in this snapshot.

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →